Home

August 8, 2022

pharmacovigilance service providers in uk

August 8, 2022

Designing a Safety and Risk Management System for Cellular Therapies

April 5, 2021

April 5, 2021

Regulatory considerations for cellular and gene therapy products in EU and US: A comparative analysis

March 9, 2021

March 9, 2021

Classification of cellular therapy and gene therapy (CGT) products: How regulators are working with industry

March 8, 2021

pharmacovigilance consulting services

March 8, 2021

End-to-end pharmacovigilance support for a UK-based pharmaceutical company

APCER’s Pharmacovigilance (PV) team supported a client’s expansion into new …

March 8, 2021

March 8, 2021

Setting up Agile PV operations for a US based Pharma company

APCER’s Pharmacovigilance (PV) team helped a biotech pharmaceutical company with …

March 8, 2021

end to end pharmacovigilance

March 8, 2021

Enabling global expansion by establishing an integrated PV system

APCER helped a global pharmaceutical company in establishing a collaborative …

January 12, 2021

January 12, 2021

Importance of Engaging a Safety Partner Early in the Drug Life Cycle

Ms. Jeanne Schow, Vice President & US Head of Business …

January 10, 2021

January 10, 2021

Quality Assurance services

Our team of experienced auditors help the bio-pharma companies achieve …

January 6, 2021

January 6, 2021

APCER Factsheet

Snapshot of end-to-end Safety services offered by APCER Life Sciences. …

December 11, 2020

December 11, 2020

Advanced Therapy Medicinal Products – The Next Therapeutic Revolution

Dr. Vineet Kacker, Managing Director & Global Technical Head talks …

November 5, 2020

November 5, 2020

Human medicinal products containing nitrosamine impurities: Regulatory landscape in the United States and the European Union